Institute for Safe Medication Practices (ISMP)’s Post

Incentivizing the European market is a key issue to fight against supply chain shortages. In this regard, the Critical Medicines Act will be an essential tool. Shortages may pose patients life at risk and we collectively should share the responsibility to stop this. EPODIN, as a member of the Critical Medicine Alliance, is fully mobilized on this issue. #POLITICOHealthCare #drugshortages #criticalmedicinesact #patientadvocacy #DINcommunity #EuropeanHealthCare

💊 Essential Medical List (EML): EML is a list of medication that satisfies the priority healthcare needs of the population. 💭 Why is the EML created? ✨ The reasons are; 📌To improve drug use. 📌Identification and avoidance of ADRs & Interactions 📌Provide Information about most effective drugs. 📌Helps in appropriate and cost effective drug control. 📌Drug management, purchase, storage and distribution. 📈The WHO model list is updated every 2 years. 🗓️The first list was published in 1977. 👦 While for the children it was published in 2007. 📜 The current version is updated in July, 2023. 👇The below is the 18th WHO Essential Drug List. 🤳 Repost if you find this helpful. 📲 Follow for more Afifa Hameed Rph #essentialmedicallist #safeuse #eml #worldhealthorganization #WHO #healthcare #patientsafety #avoidinginteractions #avoidingadversedrugreactions World Health Organization (WHO)

It’s encouraging to see a shift in perspective toward accessible health options for all. As a functional cardiologist, I believe strongly in an approach that considers the full range of tools available for optimal health. Peptides, nutraceuticals, and other natural therapies can play a valuable role in preventative and restorative health, especially for women managing heart disease and seeking alternatives beyond traditional pharmaceuticals. Empowering patients with choices outside conventional medicine not only broadens their treatment options but also aligns with a more personalized, holistic approach to health. Here’s to a future where patients have safe, effective options to support their wellness journeys—without unnecessary restrictions.

Health system staff must rigorously track medications within the hospital, effectively leverage tools and technology, and collaborate continuously to protect the community in and outside of the hospital against the risks of drug diversion. Learn three key components to a successful drug diversion program from a panel of pharmacy leaders in this expert insight. https://gag.gl/GoXpNA? #DrugDiversion #MedicationManagement #Sentri7

Following an investigation, the NHS is set to benefit from a package to address doctors’ concerns 💷 The probe from the Competition and Markets Authority will lead to £23m being offered to the NHS after it was discovered that doctors were being given misleading information. This is related to misinformation about the safety of an iron deficiency treatment. More ⬇ https://lnkd.in/ea9Wr4gE Competition and Markets Authority Juliette Enser #CMA #Health #NHS #Competition #Pharma #IronDeficiency

Find ratings for 2025 #Medicare health & drug plans now at https://lnkd.in/gSwh794E. Use star ratings to look at the quality of health & drug plans as you compare coverage options during #MedicareOE (Oct 15 – Dec. 7).

🛡️ Have you considered the impact of system downtimes on your drug diversion program? Adam Beeler, PharmD, MS, Director of Pharmacy Services at Protenus highlights why these situations present an opportunity for diverters and how organizations can proactively mitigate the risks. Learn why implementing robust workflows during downtimes is crucial for your diversion program. Don't leave your patient care and safety to chance. Find out more here: https://hubs.ly/Q02L8J0f0 #DrugDiversion #HealthcareCompliance #Hospitals #HealthcareAI

I am feeling positive about diagnostics in Africa after seeing this post about Africa CDC's pilot evaluation for regulating in-vitro diagnostics (IVDs). This initiative addresses a critical challenge identified by HealthTech Hub Africa regarding the regulatory environment for health-tech licensing processes which can be challenging, complex, lengthy and unclear. By streamlining regulatory pathways and harmonizing standards, this pilot would simplify approval processes and reduce barriers for manufacturers. #DiagnosticsAccess #Healthtech #PublicHealth

Manufacturers anticipating potential selection or therapeutic impact for 2027 #Medicare negotiations should begin preparations and align internal decision-making now. In a new #AvalereInsight, Milena Sullivan, Megan West (Olsen), Mike Ciarametaro, and J. Lance Grady detail how stakeholders can apply learnings from year 1 and begin thinking about year 2 negotiation today: https://lnkd.in/enQTvd_e #IRA #InflationReductionAct #drugpricing #healthpolicy

A controversial CMS proposal to expand coverage of GLP-1 weight loss drugs sparks debate over costs, long-term benefits, and industry impact. What does this mean for payers and patients? Click to find out. https://lnkd.in/eDFPKcnp #HealthcarePolicy #Medicare #ObesityTreatment